MassBio is partnering with the ElevateBio team on November 2 to host 2026 R&D Reimagined – Techbio Solutions, the second in a ...
Michigan's Oncology Sequencing Program, or MiOncoSeq, was the first of its kind in the nation to sequence patient tumors.
University of Michigan researchers used long-read nanopore sequencing to resolve hidden cancer-driving alterations in tumors ...
Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...
Paired-end sequencing now available on the UG200™ Series, advancing workflow compatibility and quality for germline whole ...
When you hear the term "whole-genome sequencing," don't you feel like it allows for a detailed examination of all the DNA ...
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
When reading articles about genetic testing, terms like PCR, Sanger sequencing, NGS, and digital PCR often appear.While all ...
NGS Leads as Precision Medicine, Oncology and NIPT Adoption Accelerates, While Long-Read Sequencing, AI Bioinformatics and Pharma Partnerships Unlock OpportunitiesDublin, Oct. 09, 2026 (GLOBE NEWSWIRE ...
The US Patent and Trademark Office's Patent Trial and Appeal Board rejected a challenge from Guardant Health (GH) on a DNA ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Aug 24 (Reuters) - A U.S. court has ordered Guardant Health to pay more than $245.2 million to TwinStrand Biosciences and the University of Washington after finding that the company infringed patents ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results